Electronic Journal of Biotechnology ISSN: 0717-3458
  © 2003 by Universidad Católica de Valparaíso -- Chile
Vol. 6 No. 3, Issue of December 15, 2003
 


Table 1. Hematological variables measured at baseline (day 10) and after VEGF121 gene therapy (days 20 and 40).

Hematological variables

Control

pVEGF121

Physiological valuesa

day 10

day 20

day 40

day 10

day 20

day 40

Hemoglobin (g/L)

12.31.5

13.62.2

13.82.9

12.22.0

11.31.0

13.02.5

11.0-12.5

Hematocrit (%/vol)

405

447

455

374

383

412

38-40

Glycemia (mmol/L)

4.41.8

4.40.8

4.20.7

4.31.3

4.40.4

4.10.4

4-6

Creatinin (mmol/L)

7414

8216

966

727

8911

938

50-100

Total proteins (g/L)

61.810.5

68.27.2

65.94.8

66.75.9

70.43.7

64.64.2

40-70

Albumin (g/L)

36.115.2

34.15.7

34.92.9

33.05.7

32.05.5

32.94.3

30-60

AP (U/L)

10830

12826

13732

9226

12218

13827

80-180

GPT (U/L)

2511

274

3110

173

2710

345

2-40

GOT (U/L)

5.43.2

8.11.8

8.61.5

5.81.2

6.62.0

8.22.3

5-10

Coagulation time (min)

5.71.7

9.18.9

13.313.0

5.61.4

5.71.8

5.31.0

4-8

Bleeding time (min)

1.20.2

1.10.2

1.40.3

1.30.4

1.10.2

1.30.4

1-3

Platelet counting (x109)

16341

19841

19440

19941

19347

18554

130-200

a(Tvedten, 1981)
AP: alkaline phosphatase; GPT: glutamic-pyruvic transaminase; GOT: glutamic-oxaloacetic transaminase.


Supported by UNESCO / MIRCEN network